Patientgain
Published September 7, 2026
Marketing For TMS, Ketamine and Spravato + HIPAA Compliant - PatientGain
Marketing IV ketamine as “FDA-approved for depression” violates federal law and can result in severe legal penalties or clinic shutdown. Ad Platform.
Read the full story at Patientgain
Surfaced by this Google Alert
- Ketamine
